The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma.
作者:
主题词
投药, 口服(Administration, Oral);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);环磷酰胺(Cyclophosphamide);用药计划表(Drug Administration Schedule);依托泊甙(Etoposide);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);男(雄)性(Male);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);有机化学品(Organic Chemicals);预后(Prognosis);前瞻性研究(Prospective Studies);回顾性研究(Retrospective Studies);存活率(Survival Rate);长春新碱(Vincristine)
DOI
10.1007/s10637-019-00769-5
PMID
31028663
发布时间
2020-03-09
- 浏览16

Investigational new drugs
548-558页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文